Samsung Biologics Co Ltd
KRX:207940
Samsung Biologics Co Ltd
Pre-Tax Income
Samsung Biologics Co Ltd
Pre-Tax Income Peer Comparison
Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors
Company | Pre-Tax Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Samsung Biologics Co Ltd
KRX:207940
|
Pre-Tax Income
₩1.1T
|
CAGR 3-Years
61%
|
CAGR 5-Years
30%
|
CAGR 10-Years
N/A
|
|
P
|
Peptron Inc
KOSDAQ:087010
|
Pre-Tax Income
-₩15.9B
|
CAGR 3-Years
5%
|
CAGR 5-Years
-34%
|
CAGR 10-Years
N/A
|
K
|
Knotus Co Ltd
KOSDAQ:278650
|
Pre-Tax Income
₩325.7m
|
CAGR 3-Years
-67%
|
CAGR 5-Years
-41%
|
CAGR 10-Years
N/A
|
S
|
ST Pharm Co Ltd
KOSDAQ:237690
|
Pre-Tax Income
₩23.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
F
|
FutureChem Co Ltd
KOSDAQ:220100
|
Pre-Tax Income
-₩6.7B
|
CAGR 3-Years
34%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
L
|
LegoChem Biosciences Inc
KOSDAQ:141080
|
Pre-Tax Income
-₩75.7B
|
CAGR 3-Years
-105%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
-29%
|
See Also
What is Samsung Biologics Co Ltd's Pre-Tax Income?
Pre-Tax Income
1.1T
KRW
Based on the financial report for Dec 31, 2023, Samsung Biologics Co Ltd's Pre-Tax Income amounts to 1.1T KRW.
What is Samsung Biologics Co Ltd's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 5Y
30%
Over the last year, the Pre-Tax Income growth was 11%. The average annual Pre-Tax Income growth rates for Samsung Biologics Co Ltd have been 61% over the past three years , 30% over the past five years .